Literature DB >> 11238605

Testing time-, ignorance-, and danger-based models of tolerance.

C C Anderson1, J M Carroll, S Gallucci, J P Ridge, A W Cheever, P Matzinger.   

Abstract

In this study, we present data showing that tolerance to Ags in the periphery is not determined by the time at which the Ag appears, or by special properties of tissues in newborn mice or newly developing immune systems. We placed male grafts onto immunoincompetent female mice, allowed the grafts to heal for up to 5 mo, and then repopulated the recipients with fetal liver stem cells. We found that the newly arising T cells were neither tolerant nor ignorant of the grafts, but promptly rejected them, though they did not reject female grafts, nor show any signs of autoimmunity. We also found that the H-Y Ag was continuously cross-presented on host APCs, that this presentation was immunogenic, not tolerogenic, and that it depended on the continuous presence of the graft. In searching for the stimulus that might activate the host APCs, we analyzed mRNA expression with a highly sensitive real-time quantitative PCR assay. By using two different "housekeeping" molecules for comparison, we analyzed the message levels for several stress and/or inflammatory molecules in the healed grafts. We found that the long-healed grafts were not equivalent to "normal" skin because the healed grafts expressed lower levels of GAPDH. Altogether, these data suggest that acceptance vs rejection of peripheral tissues is not attributable to ignorance, timing-based tolerance, or special circulation properties of naive T cells in neonatal tissues. It is more likely attributable to an aspect of the context of Ag presentation that remains to be identified.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11238605     DOI: 10.4049/jimmunol.166.6.3663

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  28 in total

1.  Skin allograft maintenance in a new synchimeric model system of tolerance.

Authors:  N N Iwakoshi; T G Markees; N Turgeon; T Thornley; A Cuthbert; J Leif; N E Phillips; J P Mordes; D L Greiner; A A Rossini
Journal:  J Immunol       Date:  2001-12-01       Impact factor: 5.422

2.  Intravital microscopy identifies selectins that regulate T cell traffic into allografts.

Authors:  Thomas R Jones; Nozomu Shirasugi; Andrew B Adams; Thomas C Pearson; Christian P Larsen
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

3.  Comment on: Ten experiments that would make a difference in understanding immune mechanisms.

Authors:  Colin C Anderson
Journal:  Cell Mol Life Sci       Date:  2011-11-25       Impact factor: 9.261

4.  Requirements for induction and maintenance of peripheral tolerance in stringent allograft models.

Authors:  Masayuki Sho; Koji Kishimoto; Hiroshi Harada; Mauren Livak; Alberto Sanchez-Fueyo; Akira Yamada; Xin Xiao Zheng; Terry B Strom; Giacomo P Basadonna; Mohamed H Sayegh; David M Rothstein
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-06       Impact factor: 11.205

Review 5.  The many sounds of T lymphocyte silence.

Authors:  Ignacio Melero; Ainhoa Arina; Lieping Chen
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

6.  Loss of transgene following ex vivo gene transfer is associated with a dominant Th2 response: implications for cutaneous gene therapy.

Authors:  Zhenmei Lu; Soosan Ghazizadeh
Journal:  Mol Ther       Date:  2007-03-13       Impact factor: 11.454

Review 7.  The innate immune system in allograft rejection and tolerance.

Authors:  David F LaRosa; Adeeb H Rahman; Laurence A Turka
Journal:  J Immunol       Date:  2007-06-15       Impact factor: 5.422

8.  A discussion of immune tolerance and the layered immune system hypothesis.

Authors:  Jeff E Mold; Colin C Anderson
Journal:  Chimerism       Date:  2013-05-03

Review 9.  The innate immune system in transplantation.

Authors:  Martin H Oberbarnscheidt; Daniel Zecher; Fadi G Lakkis
Journal:  Semin Immunol       Date:  2011-07-01       Impact factor: 11.130

10.  Caspase inhibitor therapy synergizes with costimulation blockade to promote indefinite islet allograft survival.

Authors:  Juliet A Emamaullee; Joy Davis; Rena Pawlick; Christian Toso; Shaheed Merani; Sui-Xiong Cai; Ben Tseng; A M James Shapiro
Journal:  Diabetes       Date:  2010-03-23       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.